KA/EN
Register
Medicines reference
Search
Search
Product

Canigen CHPPi/LR

Favourites

Canine distemper virus + Canine adenovirus + Canine parvovirus + Canine parainfluenza virus + Leptospira canicola + Leptospira icterohaemorrhagiae + Rabies virus · Virbac

1 form: suspension. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Species Dose Frequency Georgia
Suspension · Dog Dog 1 ml
For the primary course, give Canigen CHPPi/L from 8 weeks, then reconstitute Canigen CHPPi with the LR suspension and inject one 1 ml CHPPi/LR dose subcutaneously 3-4 weeks later, from 12 weeks. Give one CHPPi/LR dose one year later. Thereafter give CHPPi/L annually and CHPPi/LR every 2 years for rabies. Vaccinate healthy animals only and deworm at least 10 days beforehand. Do not use during pregnancy or lactation. Hypersensitivity, including anaphylaxis, requires immediate treatment. Rabies antibody titres required for travel are not guaranteed in every vaccinated dog.
 · second primary dose from 12 weeks, then component-specific revaccination		 second primary dose from 12 weeks, then component-specific revaccination Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: კანიგენ CHPPi/LR
№ 1-03/155
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Canigen CHPPi/LR, Suspension

lyophilisate and suspension for injection, 1 ml dose for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.9/10
Good
vetman assessment

Canigen CHPPi/LR

lyophilisate and suspension for injection, 1 ml dose for dogs
Assessed clinical scopeDog · Full dog label: immunisation against CDV, CAV, CPV, CPiV, Canicola and Icterohaemorrhagiae leptospirosis, and rabies in the CHPPi/L-to-CHPPi/LR schedule · Subcutaneous
Care settingPreventive veterinary vaccination with examination, cold-chain control, protocol tracking and emergency treatment available
vetman score 7.9/10 Good
Evidence confidence: High Georgia: Yes, veterinary · № 1-03/155 · Verified on 21 Oct 2026

A broad and well-documented combination that is operationally efficient, but its old bivalent leptospiral coverage and 12-week core endpoint mean the clinician may need a different or additional modern schedule for full risk-based protection.

Regulatory and scientific credibility9.0/10

The exact seven-antigen presentation is registered in Georgia and has long-standing valid French authorisation plus a current regulator-hosted product record and detailed SPC.

Clinical efficacy7.5/10

The core viral and rabies components have strong clinical value, but the primary schedule ends at 12 weeks rather than the guideline-preferred final core dose at 16 weeks or later, and the bivalent leptospiral component has narrower serogroup coverage than current four-serovar options.

Safety and tolerability7.5/10

The benefit-risk is favourable in healthy dogs, but injection-site reactions and lethargy are common, rare gastrointestinal or hypersensitivity reactions can occur, and immediate anaphylaxis treatment must be available.

Clinical practicality7.5/10

One 1 ml SC injection combines seven targets, but it depends on a preceding CHPPi/L dose, annual CHPPi/L follow-up, biennial rabies timing, cold chain and careful travel-document planning.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Vaccinate healthy dogs only; do not use in hypersensitivity and do not use during pregnancy or lactation.
  • The primary programme requires Canigen CHPPi/L first, followed by CHPPi/LR 3-4 weeks later from 12 weeks; this does not remove the need to consider a final core dose at 16 weeks or later.
  • The leptospiral component covers Canicola and Icterohaemorrhagiae only; compare local serogroup risk with current four-serovar alternatives.
  • Common injection-site reactions and lethargy can occur; rare gastrointestinal signs or hypersensitivity, including anaphylaxis, require prompt treatment.
  • A vaccine dose does not guarantee the rabies antibody titre required for travel; follow destination rules and allow time for serology when required.
  • Do not mix with another veterinary medicine unless the exact combination is authorised; decide other same-day or sequential use case by case.
  • Maintain the cold chain, reconstitute aseptically and administer the complete 1 ml dose promptly.
Assessment sources
  1. EU UPD Canigen CHPPi/LR2026
  2. WSAVA vaccination 20242024
  3. AAHA canine vaccination 20222022
  4. ACVIM leptospirosis consensus 20232023
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Canine distemper virus3 log10 CCID50/dose Canine adenovirus4 log10 CCID50/dose Canine parvovirus5 log10 CCID50/dose Canine parainfluenza virus5 log10 CCID50/dose Leptospira canicola833 million org/dose Leptospira icterohaemorrhagiae833 million org/dose Rabies virus1 IU/dose
Formulation Type
Suspension
Administration route
Subcutaneous
Manufacturer
Virbac · France
Manufacturer (register)
Virbac S.A., France
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 29, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: კანიგენ CHPPi/LR
№ 1-03/155
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 ml
For the primary course, give Canigen CHPPi/L from 8 weeks, then reconstitute Canigen CHPPi with the LR suspension and inject one 1 ml CHPPi/LR dose subcutaneously 3-4 weeks later, from 12 weeks. Give one CHPPi/LR dose one year later. Thereafter give CHPPi/L annually and CHPPi/LR every 2 years for rabies. Vaccinate healthy animals only and deworm at least 10 days beforehand. Do not use during pregnancy or lactation. Hypersensitivity, including anaphylaxis, requires immediate treatment. Rabies antibody titres required for travel are not guaranteed in every vaccinated dog.
 Dog Any weight Subcutaneous second primary dose from 12 weeks, then component-specific revaccination
EU UPD Canigen CHPPi/LR
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Canigen CHPPi/LR - official product information
EU Union Product Database, 2026

Canine distemper virus: No dose supported by a publicly verifiable source yet

Canine adenovirus: No dose supported by a publicly verifiable source yet

Canine parvovirus: No dose supported by a publicly verifiable source yet

Canine parainfluenza virus: No dose supported by a publicly verifiable source yet

Leptospira canicola: No dose supported by a publicly verifiable source yet

Leptospira icterohaemorrhagiae: No dose supported by a publicly verifiable source yet

Rabies virus: No dose supported by a publicly verifiable source yet

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 21 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗